Table 2.
Comorbidity | Total | ID absent | ID present |
---|---|---|---|
Charlson index, median (IQR) | 1 (2) | 0 (2)# | 2 (3)# |
Comorbid condition | |||
Myocardial infarction, n (%) | 31 (18) | 13 | 18 |
Heart failure, n (%) | 29 (17) | 10* | 19* |
Peripheral vascular disease, n (%) | 23 (13) | 9 | 14 |
Dementia, n (%) | 1 (1) | 1 | 0 |
Chronic pulmonary disease, n (%) | 18 (10) | 8 | 10 |
Musculoskeletal/connective tissue, n (%) | 9 (5) | 2* | 7* |
Ulcers, n (%) | 8 (5) | 2 | 6 |
Mild liver disease, n (%) | 3 (2) | 1 | 2 |
Kidney disease (moderate), n (%) | 16 (9) | 3 # | 13 # |
Diabetes mellitus, n (%) | 31 (18) | 9 # | 22 # |
Malignancy, n (%) | 10 (6) | 3 | 7 |
Leukaemia, n (%) | 1 (1) | 1 | 0 |
Lymphoma, n (%) | 2 (1) | 0 | 2 |
Moderate liver disease, n (%) | 0 (0) | 0 | 0 |
Metastasis of solid tumour, n (%) | 3 (2) | 1 | 2 |
Any malignancy (of the above mentioned), n (%) | 13 (7) | 4 | 9 |
Comorbidities included in the logistic regression analysis are presented in bold
Chi Square test: * p < 0.10, # p < 0.05